NACDS urges changes in PDUFA, FDA legislation
NACDS called for the enactment of provisions that would provide healthcare cost savings, expand access to medications, facilitate effective communications with consumers, and foster operational efficiency for community pharmacy.
In a letter to the chairman and ranking member of the House of Representatives' Health Subcommittee of the Committee on Energy & Commerce, NACDS called for the enactment of provisions that would provide healthcare cost savings, expand access to medications, facilitate effective communications with consumers, and foster operational efficiency for community pharmacy. NACDS' letter, which was addressed to subcommittee chairman Frank Pallone (D, N.J.) and ranking member Nathan Deal (R, Ga.), is in regard to legislation reauthorizing the Prescription Drug User Fee Act (PDUFA) and components of a broad FDA package.
To see more Hot off the Press news articles, click here.
To go to the Drug Topics homepage, click here.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
